Category: Bladder Cancer

Saracatinib (AZD0530) is a potent Src Family Inhibitor

Src is a prototypical non-receptor tyrosine kinase. It also includes c-Yes and Fyn. Src transduces signals that control processes involved in cell proliferation, adhesion, and motility. Clinical evidence supports a link between deregulation of Src activity and tumor progression and metastasis. Src over-expression and activation are associated with numerous...

A Potent and Reversible EGFR Inhibitor (E)-AG 99

(E)-AG 99 is a potent and reversible EGFR inhibitor and has potential treatment Bladder cancer. Bladder cancer (BC) is one of common malignancies worldwide. Bladder cancer is any of several types of cancers arising from the tissues of the urinary bladder. The prevalence of EGFR expression in bladder cancer...